Results 151 to 160 of about 10,063 (203)

Exploring adverse events associated with vosoritide monotherapy: Insights from the FDA Adverse Event Reporting System. [PDF]

PLoS One
Li X, Luo X, Liu F, Wang C, Li X, Yu H.
europepmc   +1 more source

Achondroplasia treatments in children aged 5 and older. [PDF]

Mol Cell Pediatr
Zakheim E, Sachdeva S, Moon D, Ortiz MN, Mistry N, Culler F.   +5 more
europepmc   +1 more source

Mitral Valve Repair in a Patient With Achondroplasia. [PDF]

JACC Case Rep
Bradshaw A, Bradshaw JC, Suffredini G, Hoover-Fong J, Gammie JS.   +4 more
europepmc   +1 more source

Achondroplasia.

Indian pediatrics, 2002
openaire   +3 more sources

Vosoritide (Voxzogo) for Achondroplasia: A Review of Clinical and Real-World Evidence. [PDF]

Cureus
Jones HL, Nania TI, Moore JM, Reed JD, Lyons AW, Potter P, Ashurst J, Holley H.   +7 more
europepmc   +1 more source

An AI-assisted tool for automated growth monitoring in pediatric achondroplasia. [PDF]

Eur J Pediatr
Cohen-Sela E, Lebenthal Y, Brener A, Regev R, Hagenäs L.   +4 more
europepmc   +1 more source

Prone positioning for spinal surgery in achondroplasia: A case study report. [PDF]

J Perioper Pract
Seguro JM, Marques P, Moura P, Vicente M, Ferrão J.   +4 more
europepmc   +1 more source

Error in Table and Text.

JAMA Pediatr
europepmc   +1 more source

Calidad de vida relacionada con la salud en acondroplásicos postalargamiento [PDF]

, 2013
Correa Vázquez, Eva, Cáceres Palou, Enrique, Ginebreda Martí, Ignacio, Universitat Autònoma de Barcelona. Departament de Cirurgia, Universitat Autònoma de Barcelona. Facultat de Medicina   +4 more
core   +1 more source

Real-World Safety and Effectiveness of Vosoritide in Achondroplasia: Results from a Single Center in Portugal. [PDF]

Adv Ther
Rua IB, Silva I, Beger C, Gomes C, Pais MJ, Mirante A, Sousa SB.   +6 more
europepmc   +1 more source